Ignite Creation Date:
2024-05-05 @ 4:44 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00304525
Status:
COMPLETED
Last Update Posted:
2020-12-19
First Post:
2006-03-17
Brief Title:
A Study to Evaluate RAF265 an Oral Drug Administered to Subjects With Locally Advanced or Metastatic Melanoma
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis